Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Clinical research is dead; long live clinical research

Nature Medicine volume 5, pages 477–478 (1999)Cite this article

Abstract

Recent years have seen a shift in medical research away from the traditional descriptive-based studies of disease, towards a molecular-based attempt to explore disease mechanism. Here, John Bell discusses how clinical research is set to benefit from the best of both worlds.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pappworth, M.H. in Human Guinea Pigs: Experimentation on Man (Routledge & Kegan Paul, London, 1967).

    Google Scholar 

  2. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).

    Article  CAS  Google Scholar 

  3. Polonsky, K.S., Sturis, J. & Bell, G.I. Seminars in medicine of the Beth Israel Hospital, Boston. Non-insulin dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334, 777–783 (1996).

    Article  CAS  Google Scholar 

  4. Duncan, S.A., Navas, M.A., Dufort, D., Rossant, J. & Stoffel, M. Regulation of a transcription factor network required for differentiation and metabolism. Science 281, 692–695 (1998).

    Article  CAS  Google Scholar 

  5. Lacey, D.L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176 (1998).

    Article  CAS  Google Scholar 

  6. Kong, Y.-Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315 (1999).

    Article  CAS  Google Scholar 

  7. Geisow, M.J. Proteomics: one small step for a digital computer, one giant leap for humankind. Nature Biotechnol. 16, 206 (1998).

    Article  CAS  Google Scholar 

  8. Zhang, L. et al. Gene expression profiles in normal cancer cells. Science 276, 1268–1272 (1997).

    Article  CAS  Google Scholar 

  9. Sakuntabhai, A. et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nature Genet. 21, 271–277 (1999).

    Article  CAS  Google Scholar 

  10. Periasamy, M. et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco (endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 274, 2556–2562 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Immunology Group Nuffield Department of Clinical Medicine University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, Headington, UK

    John I. Bell

Authors
  1. John I. Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bell, J. Clinical research is dead; long live clinical research. Nat Med 5, 477–478 (1999). https://doi.org/10.1038/8353

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/8353

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing